US FDA approves Ionis Pharma’s Tryngolza to treat adults living …
3 天之前 · Ionis Pharmaceuticals, Inc, a biotechnology company that develops RNA-targeted therapeutics, announced that the US Food and Drug Administration (FDA) has approved Tryngolza (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare ...
Zealand Pharma’s NDA for glepaglutide gets US FDA complete …
3 天之前 · Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for its New Drug Application (NDA) for glepaglutide, a long-acting GLP-2 ...
News - Pharmabiz.com
5 天之前 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Neurizon submits IND application for its lead candidate, NUZ-001 …
5 天之前 · Neurizon, a clinical-stage biotech company advancing treatments for neurodegenerative diseases, has announced the filing of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for its lead candidate, NUZ-001. This milestone is a pivotal step in enabling the ...
Neurizon files IND application to US FDA seeking approval to …
6 天之前 · Neurizon Therapeutics Limited, a clinical-stage biotech company advancing treatments for neurodegenerative diseases, announced the filing of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for its lead candidate, NUZ-001. This milestone is a pivotal step in ...
Editorial - Pharmabiz.com
2024年11月6日 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
AstraZeneca’s Imfinzi receives US FDA approval to treat patients …
2024年12月6日 · AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. The approval was granted by the Food and ...
Annovis Bio gets US FDA clearance to begin pivotal phase 3 …
2024年10月17日 · Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, 2024, 18:00 Hrs [IST]
US FDA accepts and granted Priority Review status to …
2024年8月16日 · US FDA accepts and granted Priority Review status to AstraZeneca’s sBLA for Imfinzi to treat patients with limited-stage SCLC: Cambridge, UK Friday, August 16, 2024, 16:00 Hrs [IST]
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing